Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.638,57
-1,02%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bioventus Inc (BVS) Bioventus Inc (BVS) Notizie

Bioventus Inc

BVS
10,68
0,03 (0,28%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202500:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202503:16EDGAR2Form 144 - Report of proposed sale of securities
13/1/202523:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202514:00GLOBEBioventus to Present at the 43rd Annual J.P. Morgan..
02/1/202514:00GLOBEBioventus Completes Divestiture of its Advanced..
26/12/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:37EDGAR2Form 144 - Report of proposed sale of securities
23/12/202423:34EDGAR2Form 144 - Report of proposed sale of securities
23/12/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202413:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202413:34EDGAR2Form 8-K - Current report
05/11/202413:30GLOBEBioventus Reports Third Quarter Financial Results
05/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
04/11/202422:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202412:30GLOBEBioventus to Report Third Quarter of Fiscal Year 2024..
25/10/202422:14EDGAR2Form S-3 - Registration statement under Securities Act of..
04/10/202413:45EDGAR2Form 8-K - Current report
01/10/202415:00GLOBEBioventus Announces Divestiture of its Advanced..
07/8/202422:15GLOBEBioventus to Present at the Canaccord Genuity 44th Annual..
06/8/202413:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:40EDGAR2Form 8-K - Current report
06/8/202413:30GLOBEBioventus Reports Second Quarter Financial Results
30/7/202413:30GLOBEBioventus to Report Second Quarter of Fiscal Year 2024..
19/7/202422:16EDGAR2Form 8-K - Current report
15/7/202423:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
18/6/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:53EDGAR2Form 8-K - Current report
13/6/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202423:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202413:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:33EDGAR2Form 8-K - Current report
07/5/202413:00GLOBEBioventus Reports First Quarter Financial Results
29/4/202413:30GLOBEBioventus to Report First Quarter of Fiscal Year 2024..
12/3/202412:30GLOBEBioventus Announces Fourth Quarter and Full Year 2023..
04/3/202414:00GLOBEBioventus to Report Fourth Quarter of Fiscal Year 2023..
06/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 10,67 Min: 10,60 Max: 10,83
Chiusura: 10,65

La tua Cronologia

NASDAQ
BVS
Bioventus
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci